Mutations in WNK1 result in dysregulation of the WNK1-SPAK/OSR1 pathway and cause pseudohypoaldosteronism type II (PHAII), a form of hypertension. This evidence concerns the gene OSR1 and pseudohypoaldosteronism type 2.